Cold Pain Therapy Market Worldwide Market Size, Status, Revenue, Growth Rate and Future Forecast, 2023
The global cold pain therapy market is witnessing considerable growth due to increasing geriatric population, increasing healthcare expenditure and growing awareness about cold pain therapy products. Moreover, increase in innovative product launches, increase in road accidents and sport related injuries across the globe is supporting the growth of the market.
Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/cold-pain-therapy-market/report-sample
The popularity of cold pain therapy products is due to presence of several pain relief products in market. These products include creams, gels, ointments, sprays, cold packs, rolls, cooling towels, motorized and non-motorized devices. Based on application, the musculoskeletal disorders segment lead the global market due to increasing cases of arthritis, osteoarthritis, joint pain and back pain across the globe.
Geographically, North America has been the largest market for cold pain therapy, owing to increased awareness, and easy accessibility to advanced technologies including motorized and non-motorized devices.
Globally, the cold pain therapy market is expected to witness the fastest growth in Asia-Pacific during the forecast period. The highest growth in the region is attributed to the increasing awareness about the various marketed products available over the counter including creams, gels, sprays, and cold packs, which are comparatively cheaper and easy to use.
Make Enquiry Before Buying the Report@ https://www.psmarketresearch.com/send-enquiry?enquiry-url=cold-pain-therapy-market
The key players operating in the global cold pain therapy market are Johnson & Johnson, Sanofi, 3M Company, Hisamitsu Pharmaceutical Co., Inc., Rohto Pharmaceutical Co., Ltd., Medline Industries, Inc., Beiersdorf AG, Breg, Inc., Össur HF and DJO Finance LLC.